Cancer Genetics and Genetic Testing - It's Not All in the Family - SPOC

Genetic sequencing technologies are increasingly applied in the oncology setting for a variety of purposes. Genetic testing of tumor specimens can help clarify a diagnosis and inform targeted therapies. Circulating tumor DNA can be detected in blood samples and can also guide therapy as well as monitoring for response to treatment or recurrence. Five to ten percent of cancers are the result of an underlying hereditary syndrome. Dedicated germline (i.e. hereditary) genetic tests are required to identify these syndromes, but other genetic tests may provide clues about the chance of a hereditary syndrome. Inappropriate use of other types of genetic testing to assess germline risk can result in harm to patients. We propose to provide education about various oncology genetic tests and their uses, with an emphasis on what those tests may (or may not) tell us about underlying hereditary risk. We will illustrate this with case examples, including a recent case referred to us who underwent prophylactic surgeries after being told she had BRCA1/2 associated hereditary breast and ovarian cancer syndrome following incorrect ordering of a test that did not address germline risk and misinterpretation of the results.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.

Learning Objectives

  • Differentiate between germline, tumor and cell free DNA test products and their application in cancer care.
  • Identify features of somatic test results that suggest need for hereditary cancer testing.
  • Recognize risks to patients when errors in genetic test ordering or interpretation occur.

Handouts

Taking the Course

To continue, click the button Take Course.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at unclcn@unc.edu or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Course opens: 
08/01/2022
Course expires: 
07/31/2023
Rating: 
0
Kate Foreman, MD, PhD 

Kate Foreman, MS, CGC

Clinical Assistant Professor & Genetic Counselor
Genetics
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

Kate Foreman, MS, CGC, has no relevant financial relationships with commercial interests as defined by the ACCME.

 

To receive free Continuing Education Credit for this Self-Paced, Online Course:

  • Watch the video
  • Complete the assessment with a score of 80% or better
  • Complete the evaluation
  • Download the appropriate certificate

The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency.

1.00 NCPD/CNE
The University of North Carolina at Chapel Hill is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

1.00 ACPE Pharmacist
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**

1.00 ACPE Pharmacy Tech
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**

1.00 CTR
Approved by the National Cancer Registrars Association (NCRA).

1.00 ASRT
Approved by the American Society of Radiologic Technologists (ASRT).

In most cases, regulations prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to achieve a score of 80% or better on an assessment for the Self-Paced, Online Course to receive CE credit. Please contact your individual accreditation agencies for more details.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Please login or register to take this course.